| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 05/18/2006 | WO2004058939A3 TRANSLATIONAL CONTROL BY SMALL, NON-TRANSLATABLE RNAs |
| 05/18/2006 | WO2004014306A3 Compositions and methods for the treatment of diseases exhibiting protein misassembly and aggregation |
| 05/18/2006 | US20060106197 comprises protein transduction domains; nuclear localization sequences; fusion proteins; for reversible immortalization of cells |
| 05/18/2006 | US20060105983 Cytotoxic agents |
| 05/18/2006 | US20060105982 Non-invasive gene targeting to ocular cells |
| 05/18/2006 | US20060105981 Therapeutic agents for treatment of solid tumors comprising an expression-inhibiting substance against Wilms' tumor gene (WT1) |
| 05/18/2006 | US20060105980 ARC186 aptamer PEG conjugate; transplant rejection; cardiovascular disorders; angioplasty; restenosis; specificity and affinity of the aptamer can be tightly controlled and allows the generation of leads; no toxicity or immunogenicity; chemical stability |
| 05/18/2006 | US20060105979 Synergistic inhibition of VEGF and modulation of the immune response |
| 05/18/2006 | US20060105977 Desmoglein 4 is a novel gene involved in hair growth |
| 05/18/2006 | US20060105976 RNAi modulation of ApoB and uses thereof |
| 05/18/2006 | US20060105975 Nucleic acid conjugate comprising delivery aptamer connected to oligonucleotide; delivery aptamer may be connected directly to oligonucleotide, or may be connected indirectly to oligonucleotide, such as through a linker; oligonucleotide may be therapeutic, diagnostic or imaging oligonucleotide |
| 05/18/2006 | US20060105974 Conjugates of photosensitizers and oligonucleotides for selective photochemiotherapy |
| 05/18/2006 | US20060105973 nucleosides, phosphorothioate linkages; colloids; osteoporosis; depression; metabolic disorders such as obesity, diabetes, atherosclerosis and hyperlipidemia |
| 05/18/2006 | US20060105957 Loop peptide and TGFalpha for stimulating stem cell proliferation and migration |
| 05/18/2006 | US20060105950 Morphogen compositions and use thereof to treat wounds |
| 05/18/2006 | US20060105942 Inhibition of cell division based use of analogs of neuropeptide y |
| 05/18/2006 | US20060105458 Caged tetracycline (derivatives), their generation, and their use for photoactivated gene expression |
| 05/18/2006 | US20060105429 Nucleic acid encoding protein which comprises hormone and has higher plasma stability; maintains biological activity for prolonged period in body |
| 05/18/2006 | US20060105414 drug screening for reducing development of humoral immunity; detecting of IKK alpha protein kinase activity; detecting a reduced level of phosphorylation of IKK alpha; prevent abnormal B-cell development and/or activation; pathological condition transplant rejection, autoimmune disease, leukemia |
| 05/18/2006 | US20060105413 For modulating NF- kappa B signaling |
| 05/18/2006 | US20060105344 Modulation of deubiquitinase family members |
| 05/18/2006 | US20060105333 Method for diagnosis of intestinal-type gastric tumors |
| 05/18/2006 | US20060105330 Diagnostics and remedies for malignant brain tumor |
| 05/18/2006 | US20060105327 Inhibition of the SRC kinase family pathway as a method of treating HBV infection and hepatocellular carcinoma |
| 05/18/2006 | US20060105318 Compositions and Methods for Non-targeted Activation of Endogenous Genes |
| 05/18/2006 | US20060105052 Cationic nanoparticle having an inorganic core |
| 05/18/2006 | US20060105049 Folic acid-chitosan-DNA nanoparticles |
| 05/18/2006 | US20060105018 Therapeutic driving layer for a medical device |
| 05/18/2006 | US20060104983 Regions of the protein acting as surface epitopes, capable of providing inhibitors for RLIP76. include antibodies, si- RNA directed against one or more surface epitope regions; screening chemical libraries for compounds that bind ralA binding protein 1 and effect its transport activity |
| 05/18/2006 | US20060104982 Regions of the protein acting as surface epitopes, capable of providing inhibitors for RLIP76. include antibodies, si- RNA directed against one or more surface epitope regions; antiepileptic agent; screening of chemical libraries, compounds that bind ralA binding protein 1 |
| 05/18/2006 | US20060104981 Prophylactic/therapeutic agent for cancer |
| 05/18/2006 | US20060104964 Recombinant sequence, its preparation and use |
| 05/18/2006 | US20060104963 Use of transfected stem cell population expressing an antiangiogenic fragment of human tryptophanyl tRNA synthetase (TrpRS); cell-based gene therapy |
| 05/18/2006 | US20060104962 Transfected hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith |
| 05/18/2006 | US20060104961 Mechanisms of myoblast transfer in treating heart failure |
| 05/18/2006 | US20060104956 gene expression inhibition; hairpin nucleic acids; for treatment of viral infections, tumors, and cancer |
| 05/18/2006 | US20060104955 Radiation therapy by accumulation of therapeutic radionuclides in tumor-targeting bacteria |
| 05/18/2006 | US20060104954 Recombinant adeno-associated virus virions for the treatment of lysosomal disorders |
| 05/18/2006 | US20060104953 Methods and means for enhancing skin transplantation using gene delivery vehicles having tropism for primary fibroblasts, as well as other uses thereof |
| 05/18/2006 | US20060104952 Genomic barrier to viral disease |
| 05/18/2006 | US20060104951 Akt and regulation of RA synovial fibroblast apoptosis |
| 05/18/2006 | US20060104950 Methods of Tranducing genes into T cells |
| 05/18/2006 | US20060104949 Nucleic acid comprising dicistronic message for producing antibody where cistron contains DNA coding heavy and light chains |
| 05/18/2006 | US20060104943 Vaccine comprising il-13 and an adjuvant |
| 05/18/2006 | US20060104901 Preventing or treating epithelial tissue damage or hair loss |
| 05/18/2006 | DE19608751B4 Verwendung eines Adeno-assoziierten Virus-Vektors zur Steigerung der Immunogenität von Zellen Using an adeno-associated virus vector to enhance the immunogenicity of cells |
| 05/18/2006 | CA2591474A1 Therapeutic or preventive agents for ischemic heart disease or ischemic cardiomyopathy |
| 05/18/2006 | CA2588087A1 Methods of reducing body fat |
| 05/18/2006 | CA2587469A1 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
| 05/18/2006 | CA2587451A1 Defective influenza virus particles |
| 05/18/2006 | CA2488113A1 A non-human animal alzheimer's disease model and uses thereof |
| 05/17/2006 | EP1657256A2 Compositions and methods for the treatment of tumor |
| 05/17/2006 | EP1657252A2 PGC-1, a novel brown fat PPAR gamma coactivator |
| 05/17/2006 | EP1656155A2 Use of genes differentially expressed during aging of liver for treatment and diagnosis |
| 05/17/2006 | EP1551980A4 Stabilized naked dna compositions |
| 05/17/2006 | EP1296711B1 Hpv-e7 for human papilloma virus treatment |
| 05/17/2006 | EP1268609B1 Method for preparing functionalised polyalkylenimines, composition containing same and uses thereof |
| 05/17/2006 | EP1222300B1 Lentiviral vectors for the preparation of immunotherapeutical compositions |
| 05/17/2006 | EP1214598B1 Screening for inhibitors of "paired helical filaments" |
| 05/17/2006 | EP1214409B1 Fibroblast growth factor-19 (fgf-19) nucleic acids and polypeptides and methods of use for the treatment of obesity |
| 05/17/2006 | EP1135515B1 Use of trans-activation and cis-activation to modulate the persistence of expression of a transgene |
| 05/17/2006 | EP1109914B1 Heme oxygenase 1 for the inhibition of smooth muscle cell migration |
| 05/17/2006 | EP1048727B1 Gene encoding novel transmembrane protein |
| 05/17/2006 | EP0949333B1 Measles virus mutant antigen and gene encoding the same |
| 05/17/2006 | EP0831148B1 Human adhesion molecule occludin |
| 05/17/2006 | CN1773636A Water-base magnetic liquid and producing method thereof |
| 05/17/2006 | CN1772897A Cell factor with several functions |
| 05/17/2006 | CN1772894A Small interference RNA inhibiting the expression of 1A6/DRIM gene and its action site |
| 05/17/2006 | CN1772306A Group-B type-III Coxsackie virus gene vaccine |
| 05/17/2006 | CN1772305A Group-B type-I Coxsackie virus gene vaccine |
| 05/17/2006 | CN1772304A Group-B type-II Coxsackie virus gene vaccine |
| 05/17/2006 | CN1772298A The pIL-6 gene adjuvant for pig vaccine and its prepn process |
| 05/17/2006 | CN1772297A The pIFN-gamma gene adjuvant for pig vaccine and its prepn process |
| 05/17/2006 | CN1256149C Vector for gene therapy of rh TPO insect bacillar virus and its preparing process and application |
| 05/16/2006 | US7045616 Expression vector coding polypeptides for use in the treatment of alzheimer's dieases and tumors |
| 05/16/2006 | US7045614 LIM mineralization protein splice variants |
| 05/16/2006 | US7045604 Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof |
| 05/16/2006 | US7045596 Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof |
| 05/16/2006 | US7045594 Serine proteinase inhibitors |
| 05/16/2006 | US7045576 Adjuvants and copolymer compositions |
| 05/16/2006 | US7045508 Use of rapamycin to inhibit immune response and induce tolerance to gene therapy vector and encoded transgene products |
| 05/16/2006 | US7045356 polyelectrolyte complexes condensed and crosslinked with macromolecules such as polymers, nucleic acids, proteins or drugs; used to deliver biologically active compounds to a cell |
| 05/16/2006 | US7045351 Comprises protein with mitogenic/dual oxidase activity for stimulating production of oxygen intermediates such as superoxide; drug screening |
| 05/16/2006 | US7045347 Helper dependent adenovirus vectors based on integrase family site-specific recombinases |
| 05/16/2006 | US7045346 Nucleic acid constructs useful for glucose regulated production of human insulin in somatic cell lines |
| 05/16/2006 | US7045344 Adenoviral vector and methods for making and using the same |
| 05/16/2006 | US7045335 Immunotherapy; genetic engineering; anticancer agents |
| 05/16/2006 | US7045324 Tocopherol associated protein (TAP-38) DNA/protein with a 76 nucleotide base deletion resulting in a 25 amino acid deletion, followed by 90 novel nucleotides that code for 30 novel amino acids that are not expressed by TAP-46. The |
| 05/16/2006 | US7045315 Methods for modulating expression of exogenous genes in mammalian systems |
| 05/16/2006 | US7045306 assay comprising transcriptional and cognate activators with Huntington's disease mutant protein; linked to detectable sequence within neuron; for preventing or treating a neurodegenerative disease associated with an expanded polyglutamine tract |
| 05/16/2006 | US7045302 Expressed ligand-vascular intercellular signaling molecule |
| 05/16/2006 | US7045284 Reducing translation of Rna virus; genetic engineered nucleic acids |
| 05/16/2006 | US7045148 Recovering embryonic-like stem cells from a placenta; obtain placenta, drain cord blood, flush placenta with anticoagulant solution, recover cells |
| 05/16/2006 | US7045128 Antibodies against flt3-ligand |
| 05/16/2006 | US7045126 Genetic engineering; isolation polypeptides; heterogeneity amino acid sequences |
| 05/11/2006 | WO2006050414A2 Antisense antiviral compounds and methods for treating filovirus infection |
| 05/11/2006 | WO2006050274A2 Methods and compositions for cytokine expression and treatment of tumors |
| 05/11/2006 | WO2006050026A2 Compositions and methods for treating cancer using compositions comprising an inhibitor of endothelin receptor activity |
| 05/11/2006 | WO2006049812A2 Process for treating a biological organism |
| 05/11/2006 | WO2006048768A2 Kit of parts designed for implementing an antitumoral or antiviral treatment in a mammal |